Cylex's Series B Round

Cylex raised a round of funding on June 21, 2004.

Cylex is a global life science company that develops, manufactures and commercializes in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine. ImmuKnow is a non…

Articles about Cylex's Series B Round: